Maximum Dose of Nortriptyline
The maximum recommended dose of nortriptyline is 150 mg/day for adults, with doses above this level not recommended. 1
Standard Adult Dosing
The FDA-approved dosing for nortriptyline follows this framework 1:
- Starting dose: 25 mg 3-4 times daily (or as a single daily dose)
- Titration: Begin at low levels and increase gradually based on clinical response
- Maximum dose: 150 mg/day
- Doses above 150 mg/day are explicitly not recommended 1
When doses exceed 100 mg/day, plasma level monitoring becomes essential and should be maintained in the optimal therapeutic range of 50-150 ng/mL 1. This therapeutic window is critical—higher concentrations are associated with increased adverse effects rather than improved efficacy 2.
Elderly Patients: Critical Dose Adjustments
For elderly patients, substantially lower doses of 30-50 mg/day in divided doses are recommended 1. This represents a significant reduction from standard adult dosing and reflects important age-related considerations:
- Elderly patients show higher plasma concentrations of the active metabolite 10-hydroxynortriptyline, which has been associated with cardiotoxicity even when parent drug levels appear therapeutic 1
- Lower starting doses and slower titration are mandatory in geriatric populations 2, 3
- Confusional states are more common in elderly patients receiving tricyclic antidepressants 1
The evidence from frail elderly nursing home residents (average age 84) demonstrates that an average dose of only 80 mg/day achieves therapeutic plasma levels of 100 ng/mL, though individual variation is substantial 4. In this vulnerable population, doses as low as 10-13 mg/day have shown efficacy in some patients 5.
Hepatic Impairment Considerations
While the provided evidence does not contain specific nortriptyline dosing recommendations for hepatic impairment, caution is warranted given that nortriptyline undergoes extensive hepatic metabolism via CYP2D6, CYP3A4, CYP2C19, and CYP1A2 6. The FDA label emphasizes careful dose adjustment and close supervision 1, suggesting:
- Start with lower doses
- Titrate more slowly
- Monitor plasma levels closely when doses exceed 100 mg/day
- Consider that reduced hepatic function may significantly increase drug exposure
Critical Monitoring Parameters
Plasma level monitoring is not just recommended but essential when:
- Doses exceed 100 mg/day 1
- Treating elderly patients 1
- Clinical response is inadequate or adverse effects emerge
- Drug interactions are present (particularly with CYP2D6 inhibitors like fluoxetine, quinidine, or cimetidine) 1
Important Caveats
The combination of CYP2D6 poor metabolizer status and low CYP3A4 activity creates a 90% risk of toxic concentrations 6. This underscores why:
- Therapeutic drug monitoring is invaluable for nortriptyline
- Individual dose requirements can vary by a factor of 20 4
- Clinical findings should predominate over plasma concentrations as primary determinants of dosage changes 1
Common pitfall: Assuming all elderly patients require the same dose reduction. While 30-50 mg/day is the recommended range 1, some frail elderly may respond to doses as low as 10-13 mg/day 5, while others may require higher doses within the elderly range. Plasma level monitoring resolves this uncertainty.
Drug interactions are particularly problematic: Fluoxetine can cause greater than 2-fold increases in previously stable nortriptyline levels due to CYP2D6 inhibition, with effects persisting for weeks due to fluoxetine's long half-life 1. When switching between these medications or adding CYP2D6 inhibitors, dose reductions of 50% or more may be necessary.